7alpha,26-Dihydroxy-4-cholesten-3-one (BioCAD00000005494)
{$topic}
Metabolite Card
Formula: C27H44O3 (416.329)
SMILES: CC(CO)CCC[C@@H](C)C1CCC2C3[C@H](O)CC4=CC(=O)CC[C@]4(C)C3CC[C@]12C
Synonyms [en]
7alpha,26-dihydroxycholest-4-en-3-one; 4-cholesten-7alpha,26-diol-3-one; 7 alpha,26-Dihydroxy-4-cholesten-3-one; 7,26-Dhxyclso; 7alpha,26-Dihydroxy-4-cholesten-3-one; 7α,27-dihydroxycholestenone
Last reviewed on 2024-06-28.
Cite this Page
7alpha,26-Dihydroxy-4-cholesten-3-one. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000005494). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
7 alpha,26-Dihydroxy-4-cholesten-3-one is involved in primary bile acid biosynthesis. 7 alpha,26-Dihydroxy-4-cholesten-3-one is produced from 7 alpha,27-Dihydroxycholesterol through the action of HSD3B7 (EC:1.1.1.181). 7 alpha,26-Dihydroxy-4-cholesten-3-one can then be converted to 7 alpha-Hydroxy-3-oxo-4-cholestenoate by CYP27A (EC:1.14.13.15).
DBLinks
- CAS Registry Number: 4675-38-1
- PubChem CID: 53481412
- ChEBI: 190406
- HMDB: HMDB0012459
- LipidMaps: LMST04030157
- KEGG: C17336
- BioCyc:
- NCBI MeSH:
- Wikipedia:
Other DBLinks
- CAS Registry Number: 4675-38-1
- PubChem: 193396
- PubChem: 53481412
- ChEBI: ChEBI:190406
- ChEBI: ChEBI:48825
- HMDB: HMDB0012459
- LipidMaps: LMST04030157
- KEGG: C17336
- Metlin: METLIN_43144
- Metlin: METLIN_57919
- Coconut NaturalProduct: CNP0082291.2
Class / Ontology
- WishartLab ClassyFire: [Bile acids, alcohols and derivatives] Bile acids, alcohols and derivatives
- LipidMaps: [C27 bile acids, alcohols, and derivatives [ST0403]] C27 bile acids, alcohols, and derivatives [ST0403]
- ChEBI: [CHEBI:48825] 7alpha,26-dihydroxycholest-4-en-3-one
- ChEBI: [CHEBI:190406] 7 alpha,26-Dihydroxy-4-cholesten-3-one
- Coconut NaturalProduct: [Cholestane steroids] Cholestane steroids
| ID | EC Number | Name |
|---|---|---|
| KEGG:R08724 | 1.1.1.181 | 7alpha,27-dihydroxycholesterol:NAD+ 3-oxidoreductase |
| KEGG:R08725 | C17336 + 2 C00007 + 2 C00005 + 2 C00080<=>C17337 + 2 C00006 + 3 C00001 |
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| PathBank:SMP0120468 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0000318 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0120697 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0120463 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0120467 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0120495 | Zellweger Syndrome |
| PathBank:SMP0000035 | Bile Acid Biosynthesis |
| PathBank:SMP0000314 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0000315 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0087329 | Bile Acid Biosynthesis |
| PathBank:SMP0120652 | 27-Hydroxylase Deficiency |
| PathBank:SMP0120688 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0120477 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0000317 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0087236 | Bile Acid Biosynthesis |
| PathBank:SMP0120683 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0120687 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0120715 | Zellweger Syndrome |
| PathBank:SMP0120871 | 27-Hydroxylase Deficiency |
| PathBank:SMP0000316 | Zellweger Syndrome |